title: Gynecomastia: when is treatment indicated?
abstract: This algorithmic approach can simplify your clinical evaluation and help you decide whether intervention or watchful waiting is appropriate.
authors: Department of Family Medicine, St. Elizabeth Health Center, Youngstown, Ohio, USA. roymorcos@gmail.com
authors: Roy N
authors: RN
authors: Morcos
authors: Thomas
authors: T
authors: Kizy
mesh_terms: D000367:Age Factors; D019468:Disease Management; D064420:Drug-Related Side Effects and Adverse Reactions / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D012739:Gonadal Steroid Hormones / Q000378:metabolism / Q000627:therapeutic use; D006177:Gynecomastia / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008487:Medical History Taking / Q000379:methods; D054539:Medication Therapy Management; D008875:Middle Aged; D010808:Physical Examination / Q000379:methods; D010902:Pituitary Gland / Q000378:metabolism / Q000473:pathology; D010911:Pituitary Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000378:metabolism; D011388:Prolactin / Q000378:metabolism*; D015175:Prolactinoma / Q000150:complications* / Q000175:diagnosis / Q000378:metabolism; D016032:Randomized Controlled Trials as Topic
chemical_list: D012739:Gonadal Steroid Hormones; D011388:Prolactin